Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

Therapy timing, patient factors, and emerging combination interventions are guiding treatment decisions in multiple myeloma and lymphoma.

A 70-year-old white male, who had been diagnosed with IgA lambda multiple myeloma 4 months previously, was referred to the Mayo Clinic for further evaluation of anemia. The patient had required ...

Nat Clin Pract Gastroenterol Hepatol. 2007;4(2):111-115.

Multiple myeloma (MM) is a malignancy of terminally differentiated B cells. The diagnosis requires the presence of ≥ 10 % clonal plasma cells (PC) in the bone marrow or an extramedullary plasmacytoma ...

A study by the American Cancer Society has found that being overweight or obese increases a person’s risk of developing myeloma. Many people with other plasma cell diseases like MGUS or solitary ...

Multiple myeloma (MM) is a cancer that is found in plasma cells. When these malignant plasma cells are formed, they grow uncontrollably and produce what is known as a specific tumor called a ...

Further research is necessary to optimize treatment protocols and long-term surveillance strategies due to the potential risk of recurrence or progression to multiple myeloma. Solitary plasmacytoma ...

Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood cells that produce infection-fighting antibodies. Multiple myeloma is not hereditary, meaning it is not passed ...

In spite of recent advances in the management of multiple myeloma, cure has been elusive, with efforts to improve long-term ...

Study reveals multiple high-risk genetic changes predict worse multiple myeloma outcomes across all treatments.